Horizon Therapeutics Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 0.02%55.246.5%$162.29m
CTLTCatalent, Inc. -0.87%72.742.1%$126.75m
JAZZJazz Pharmaceuticals Plc 0.13%109.752.4%$111.48m
VRXValeant Pharmaceuticals International, Inc. -0.43%18.3414.1%$107.92m
BHCBausch Health Cos., Inc. -0.43%18.340.0%$80.86m
UTHRUnited Therapeutics Corp. -0.55%120.3314.3%$73.10m
ICPTIntercept Pharmaceuticals, Inc. 1.23%47.0916.8%$61.07m
AXSMAxsome Therapeutics, Inc. -3.50%80.971.9%$52.73m
ZGNXZogenix, Inc. 0.41%29.197.5%$50.72m
PRGOPerrigo Co. Plc 0.64%55.186.8%$49.09m
MYOKMyoKardia, Inc. 0.29%94.111.8%$46.94m
AMRNAmarin Corp. Plc -1.57%6.921.6%$43.50m
ARGXargenx SE 0.38%228.720.0%$40.18m
PCRXPacira Biosciences, Inc. -1.45%52.3710.3%$40.00m
ICLRICON plc -0.55%166.914.3%$38.56m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.